Inventor · disambiguated record
Johannes Brozy
Also filed as: BROZY JOHANNES
7 granted patents·13 pending applications·51 citations·filing 2013–2025
83Inventor score
Top patents by PatentIndex Score
20 records- 0195US10301391B2BCMA and CD3 bispecific T cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2017·Granted May 28, 2019·28 cites·19 claims
- 0292US10781264B2PSMA and CD3 bispecific T cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2017·Granted Sep 22, 2020·8 cites·22 claims
- 0391US11692031B2Antibody constructs for CLDN18.2 and CD3AMGEN RES MUNICH GMBH·Filed 2019·Granted Jul 4, 2023·6 cites·18 claims
- 0491US11434302B2Bispecific T cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2017·Granted Sep 6, 2022·7 cites·19 claims
- 0584US11352433B2BCMA and CD3 bispecific T cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2019·Granted Jun 7, 2022·2 cites·23 claims
- 0672US2023057728A1Long life polypeptide binding moleculesAMGEN RES MUNICH GMBH·Filed 2022·Application pending·0 cites
- 0772US2023192884A1Bispecific t cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2022·Application pending·0 cites
- 0870US2024174745A1Antibody Constructs for CLDN18.2 and CD3AMGEN RES MUNICH GMBH·Filed 2023·Application pending·0 cites
- 0969US12428491B2PSMA and CD3 bispecific T cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2020·Granted Sep 30, 2025·0 cites·28 claims
- 1068US2025333537A1Psma and cd3 bispecific t cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2025·Application pending·0 cites
- 1168US2025163177A1Bispecific t cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2025·Application pending·0 cites
- 1262US2025333536A1Mageb2 binding constructsAMGEN INC·Filed 2025·Application pending·0 cites
- 1358US12312412B2MAGEB2 binding constructsAMGEN INC·Filed 2021·Granted May 27, 2025·0 cites·11 claims
- 1456US2019169295A1Long life polypeptide binding moleculesAMGEN RES MUNICH GMBH·Filed 2018·Application pending·0 cites
- 1555US2024209078A1Multitargeting bispecific antigen-binding molecules of increased selectivityAMGEN INC·Filed 2021·Application pending·0 cites
- 1654US2015037334A1Long life polypeptide binding moleculesAMGEN RES MUNICH GMBH·Filed 2013·Application pending·0 cites
- 1753US2025129160A1T cell engager molecules and uses thereofAMGEN RES MUNICH GMBH·Filed 2022·Application pending·0 cites
- 1851US2023406887A1Antigen binding domain with reduced clipping rateAMEGEN INC·Filed 2021·Application pending·0 cites
- 1950US2022227888A1Bispecific binding constructs with selectively cleavable linkersAMGEN INC·Filed 2020·Application pending·0 cites
- 2049US2025277024A1Molecules with multiple binding domainsAMGEN INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Johannes Brozy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →